Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer. Issue 4 (15th January 2015)

• Record Type: Journal Article
• Authors: Chien, Wenwen; Sun, Qiao-Yang; Lee, Kian Leong; Ding, Ling-Wen; Wuensche, Peer; Torres-Fernandez, Lucia A.; Tan, Siew Zhuan; Tokatly, Itay; Zaiden, Norazean; Poellinger, Lorenz; Mori, Seiichi; Yang, Henry; Tyner, Jeffrey W.; Koeffler, H. Phillip
• Is Part Of: Molecular oncology. Volume 9:Issue 4(2015:Apr.)
• Page Start: 889
• Page End: 905
• Publication Date: 2015-01-15
• Subjects: PP2A -- Dasatinib -- Pancreatic cancer -- Phenothiazine -- FTY-720; Cancer -- Molecular aspects -- Periodicals; 616.994005
• DOI: 10.1016/j.molonc.2015.01.002
• Languages: English
• ISSNs: 1574-7891

Abstract

Abstract : We utilized three tiers of screening to identify novel therapeutic agents for pancreatic cancers. First, we analyzed 14 pancreatic cancer cell lines against a panel of 66 small‐molecule kinase inhibitors and dasatinib was the most potent. Second, we performed RNA expression analysis on 3 dasatinib‐resistant and 3 dasatinib–sensitive pancreatic cancer cell lines to profile their gene expression. Third, gene profiling data was integrated with the Connectivity Map database to search for potential drugs. Thioridazine was one of the top ranking small molecules with highly negative enrichment. Thioridazine and its family members of phenothiazine including penfluridol caused pancreatic cancer cell death and affected protein expression levels of molecules involved in cell cycle regulation, apoptosis, and multiple kinase activities. This family of drugs causes activation of protein phosphatase 2 (PP2A). The drug FTY‐720 (activator of PP2A) induced apoptosis of pancreatic cancer cells. Silencing catalytic unit of PP2A rendered pancreatic cancer cells resistant to penfluridol. Our observations suggest potential therapeutic use of penfluridol or similar agent associated with activation of PP2A in pancreatic cancers. Highlights: 66 kinase inhibitors were tested in 14 human pancreatic cancer cell lines. Gene expression was profiled in dasatinib resistant versus sensitive cell lines. Connectivity Map database was used for in silico drug screening. Drugs from phenothiazine family caused pancreatic cancer cell death.